冠状动脉生理学超越冠脉血流储备:微血管性心绞痛的JACC综述
该综述探讨无血管造影狭窄的心绞痛(微血管性心绞痛)的冠状动脉生理学,指出综合定量心肌灌注可超越冠脉血流储备提供新见解。通过整合负荷绝对血流、相对血流、冠脉血流储备和心内膜下灌注梯度,对5,900例进行精准定量心肌灌注,将无狭窄心绞痛客观分为四类,其中95%与危险因素或冠状动脉粥样硬化相关。
要点
- 无血管造影狭窄的心绞痛常与异常定量灌注相关,但微血管功能障碍不伴心绞痛也常见。
- 综合定量心肌灌注可对无狭窄心绞痛进行生理分类,指导治疗。
- 95%的无狭窄心绞痛患者与危险因素或亚临床/临床冠状动脉粥样硬化相关,需强化危险因素治疗。
核心结论
- 综合定量心肌灌注可对无血管造影狭窄的心绞痛进行正确诊断、定量生理分类和潜在治疗指导。
研究设计与样本
- JACC state-of-the-art综述,基于5,900例精准定量心肌灌注病例。
主要发现
- 无血管造影狭窄的心绞痛与异常定量灌注相关,罕见但有启发性的例外。
- 无狭窄心绞痛客观分为四类:弥漫冠状动脉疾病所致心内膜下缺血(最常见)、被忽略的狭窄、危险因素或特定微血管病所致弥漫微血管功能障碍、非缺血性心脏疼痛机制(罕见),或这些原型的混合。
- 95%的无狭窄心绞痛与危险因素、亚临床或临床冠状动脉粥样硬化相关。
关键数值与推荐
- 整合区域绝对负荷血流、相对负荷血流、冠脉血流储备和相对图像断层扫描上的定性心内膜下灌注梯度。
- 心内膜下/心外膜相对活性降低常见于无局灶性狭窄的弥漫冠状动脉疾病,伴或不伴心绞痛取决于心内膜下灌注降低的严重程度。
临床怎么用
- 对无血管造影狭窄的心绞痛患者,应进行综合定量心肌灌注评估以明确诊断和生理分类。
- 多数患者需强化危险因素治疗,针对亚临床或临床冠状动脉粥样硬化。
局限性
- 无血管造影狭窄的心绞痛涵盖广泛的冠状动脉病理生理连续谱,已发表报告存在矛盾。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Angina with no angiographic stenosis, commonly called "microvascular angina," encompasses a wide continuum of coronary pathophysiology in conflicting published reports. Comprehensive quantitative myocardial perfusion offers new insights beyond overly simplistic coronary flow reserve. Integrating regional absolute stress flow, relative stress flow, coronary flow reserve, and qualitative subendocardial perfusion gradient on tomograms of relative images, provides correct diagnosis, quantitative physiological classification, and potential treatment. Angina without angiographic stenosis is associated with abnormal quantitative perfusion with rare, but instructive, exceptions. However, microvascular dysfunction without angina is common, particularly associated with risk factors. Reduced subendocardial/epicardial relative activity is common with diffuse coronary artery disease without focal stenosis with or without angina depending on the severity of reduced subendocardial perfusion. Precision quantitative myocardial perfusion in 5,900 cases objectively classifies angina with no angiographic stenosis into 4 categories: subendocardial ischemia due to diffuse coronary artery disease (most common), overlooked stenosis, diffuse microvascular dysfunction due to risk factors or specific microvasculopathies, and nonischemic cardiac pain mechanisms (rare), or some mix of these prototypes, of which 95% associate with risk factors, or subclinical or clinically manifest coronary atherosclerosis needing vigorous risk factor treatment.
引用
- Gould KL, Johnson NP. Coronary Physiology Beyond Coronary Flow Reserve in Microvascular Angina: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018. PMID: 30466522. doi:10.1016/j.jacc.2018.07.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。